Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Jun 2023. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 12074591000202117 | Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 12074601000202113 | Benzyl benzoate and disulfiram only product in cutaneous dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) | Is a | Product containing only benzyl benzoate and disulfiram (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) | Is a | Benzyl benzoate-containing product in cutaneous dose form | true | Inferred relationship | Some | ||
| Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Some | ||
| Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) | Plays role | Scabicide therapeutic role | false | Inferred relationship | Some | ||
| Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) | Has active ingredient | Disulfiram (substance) | true | Inferred relationship | Some | 1 | |
| Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) | Has active ingredient | Benzyl benzoate (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely benzyl benzoate 225 milligram/1 gram and disulfiram 20 milligram/1 gram conventional release cutaneous emulsion (clinical drug) | Is a | True | Product containing only benzyl benzoate and disulfiram in cutaneous dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR